Related Experiment Video
Updated: Jun 5, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Antibiotic multiresistance in critical care units]
M J López-Pueyo1, F Barcenilla-Gaite, R Amaya-Villar
1Servicio de Medicina Intensiva, Complejo asistencial de Burgos, Burgos, España. mjlp@hgy.es
Medicina Intensiva
|January 11, 2011
Summary
Managing critically ill patients with multidrug-resistant organisms requires intensivists to control transmission and select appropriate antibiotic treatments. This review covers resistance, control measures, and treatment strategies, including national data.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Microbiology
Background:
- Multidrug-resistant organisms (MDROs) pose significant challenges in intensive care units (ICUs).
- Intensivists play a crucial role in preventing and controlling MDROs and managing infections.
- Effective antibiotic stewardship is vital for patient outcomes.
Purpose of the Study:
- To review the literature on multidrug resistance in critically ill patients.
- To discuss transmission, control measures, and treatment options for MDRO infections.
- To present national data on multidrug resistance in ICUs.
Main Methods:
- Comprehensive literature review on multidrug resistance.
- Analysis of transmission dynamics and control strategies.
- Inclusion of national surveillance data (ENVIN-UCI register).
Main Results:
- Multidrug resistance complicates patient management and outcomes in critical care.
- Effective control requires a multi-faceted approach, including infection prevention and appropriate treatment.
- National data highlights the prevalence and impact of MDROs.
Conclusions:
- Addressing multidrug resistance necessitates specialized training for intensivists.
- Teamwork with other specialists and local environmental adaptation are essential.
- Proactive strategies are crucial for combating MDROs in ICUs.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
00:57Antibiotic Selection
Overview
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...